Parkman Healthcare Partners’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-116,107	Closed	-$5.87M	–	91
2023 Q3	$5.87M	Buy	116,107 +81,107	+232%	+$4.1M	1.08%	30
2023 Q2	$1.63M	Buy	+35,000	New	+$1.63M	0.28%	81
2020 Q3	–	Sell	-95,000	Closed	-$2.37M	–	85
2020 Q2	$2.37M	Buy	+95,000	New	+$2.37M	0.67%	50